Residual Solvents Reports
Are you looking to ensure compliance with regulations regarding residual solvents in pharmaceutical products?
At QbD Group, we specialize in risk assessments for residual solvents in both human and veterinary drug products. Our expert team helps you identify potential risks, generate comprehensive risk assessment reports, and address regulatory agency concerns. With a dedicated team of toxicology professionals, we can develop customized toxicology reports to meet your specific needs and regulatory requirements.
What is residual solvent risk assessment?
Residual solvent risk assessment is a comprehensive evaluation of drug substances, excipients, and manufacturing processes aimed at identifying and mitigating risks associated with residual solvents. This process is designed to protect patients from potential adverse effects. It includes three key steps:
- Analyzing potential residual solvents introduced during the manufacturing process.
- Evaluating actual or predicted solvent levels and comparing them against established Permitted Daily Exposure (PDE) values.
- Defining an effective control strategy based on the findings.
By following these steps, we help ensure compliance with regulatory standards while prioritizing patient safety.
The importance of managing residual solvents in pharmaceuticals
Residual solvents in pharmaceuticals are organic volatile chemicals used or produced during the manufacture of drug substances, excipients, or products. According to the ICH Q3C guideline, these solvents offer no therapeutic benefit and can pose potential risks to patient safety. Therefore, it is crucial to remove them to the greatest extent possible to meet product specifications, Good Manufacturing Practices (GMPs), and other quality-based requirements.
By conducting a thorough residual solvent risk assessment, you ensure that your products meet regulatory standards, protect patient health, and maintain product quality throughout the manufacturing process.
What are the benefits?
An updated, documented repository of residual solvent risk assessments ensures that you are prepared for regulatory inspections and audits, providing the necessary documentation authorities may request.
How we work: our process for residual solvent risk assessment
At QbD Group, we follow a structured approach to ensure a thorough and compliant residual solvent risk assessment for your pharmaceutical products. Here’s how we work:
Step 1
Step 2
Step 3
Step 4
Step 5
Why QbD Group?
For more than 10 years, QbD Group has been a trusted partner in Toxicology Services, providing expert advice and support to mitigate and control quality risks across the life sciences industry.
- Our Toxicology Team holds membership in AETOX, a benchmark organization in toxicology.
- Our experts are certified by EUROTOX, ensuring we meet the highest professional standards.
Whether you need comprehensive PDE reports or expert toxicological support, QbD Group is ready to help you ensure safety, quality, and compliance in every step of your operations.
10+ years of experience
Full lifecycle support
Global presence
Best Managed Company
Get in touch
Reach out for expert guidance on residual solvent risk assessments.
Have questions or need more information? Fill out the form, and our team will be happy to help you with tailored solutions for your pharmaceutical products.